Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t209
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 664k | $6.4M | 0% | Jun 2026 |
|
| OrbiMed Advisors | 592k | $5.7M | 100% | Jun 2026 |
|
| Frazier Life Sciences Management | 423k | $4.0M | 0% | Jun 2026 |
|
| Stonepine Capital Management | 226k | $2.2M | 252% | Jun 2026 |
|
| Vanguard Capital Management | 179k | $1.7M | 44% | Jun 2026 |
|
| Sio Capital Management | 153k | $1.5M | 0% | Jun 2026 |
|
| Adage Capital Partners GP | 112k | $1.1M | 100% | Jun 2026 |
|
| Merck & Co | 106k | $1.0M | 0% | Jun 2026 |
|
| Renaissance Technologies | 64k | $615k | 29% | Jun 2026 |
|
| Morgan Stanley | 58k | $484k | 100% | Mar 2026 |
|
| Geode Capital Management | 39k | $374k | 5% | Jun 2026 |
|
| Citadel Advisors | 26k | $249k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 23k | $217k | -21% | Jun 2026 |
|
| Bridgeway Capital Management | 18k | $168k | 100% | Jun 2026 |
|
| Two Sigma Investments | 15k | $139k | 100% | Jun 2026 |
|
| Velan Capital Investment Management | 14k | $137k | 0% | Jun 2026 |
|
| GSA Capital Partners | 14k | $130k | -20% | Jun 2026 |
|
| State Street Corporation | 13k | $112k | 100% | Mar 2026 |
|
| Springbok Capital Management | 12k | $111k | 100% | Jun 2026 |
|
| BlackRock | 8.8k | $84k | 100% | Jun 2026 |
|
| CWM | 4.2k | $35k | 100% | Mar 2026 |
|
| Steward Partners Investment Advisory | 714.00 | $6.8k | 100% | Jun 2026 |
|
| Barclays | 115.00 | $1.1k | 100% | Jun 2026 |
|
| Key FInancial | 59.00 | $565.001700 | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 29.00 | $262.000500 | 100% | Jun 2026 |
|
| UBS Group | 14.00 | $133.999600 | -100% | Jun 2026 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caligan Partners | Mar 2026 | 112k | $943k |
| AJU IB Investment | Mar 2026 | 48k | $401k |
| FMR | Mar 2026 | 37k | $308k |
| Ghisallo Capital Management | Mar 2026 | 14k | $116k |
| Vanguard Global Advisers | Mar 2026 | 210.00 | $1.8k |
| Royal Bank of Canada | Mar 2026 | 91.00 | $999.999000 |